{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:17:23Z","timestamp":1761175043217,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Central Africa Network on Clinical Research"},{"DOI":"10.13039\/501100001713","name":"European & Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijid.2019.04.035","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T14:03:40Z","timestamp":1557410620000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo"],"prefix":"10.1016","volume":"85","author":[{"given":"Simon Marie","family":"Peko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-050X","authenticated-orcid":false,"given":"Francine","family":"Ntoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christevy","family":"Vouvoungui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nderu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Charles","family":"Kobawila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-9883","authenticated-orcid":false,"given":"Thirumalaisamy P.","family":"Velavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Koukouikila-Koussounda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2019.04.035_bib0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/pr.115.011411","article-title":"Role of cytochrome P450 2C8 in drug metabolism and interactions","volume":"68","author":"Backman","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.ijid.2019.04.035_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/emph\/eot010","article-title":"African variation at cytochrome P450 genes: evolutionary aspects and the implications for the treatment of infectious diseases","volume":"2013","author":"Bains","year":"2013","journal-title":"Evol Med Public Health"},{"issue":"1","key":"10.1016\/j.ijid.2019.04.035_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00228-004-0871-8","article-title":"CYP2C8 polymorphism frequencies among malaria patients in Zanzibar","volume":"61","author":"Cavaco","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ijid.2019.04.035_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/infdis\/jis736","article-title":"CYP2C8 status of patients with malaria influences selection of Plasmodium falciparum pfmdr1 alleles after amodiaquine-artesunate treatment","volume":"207","author":"Cavaco","year":"2013","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2019.04.035_bib0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00008571-200110000-00006","article-title":"Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid","volume":"11","author":"Dai","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"9","key":"10.1016\/j.ijid.2019.04.035_bib0030","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2217\/pgs.09.82","article-title":"Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies","volume":"10","author":"Daily","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.ijid.2019.04.035_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/14622416.8.2.187","article-title":"CYP2C8 and antimalaria drug efficacy","volume":"8","author":"Gil","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.ijid.2019.04.035_bib0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/geno.1995.1149","article-title":"A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24","volume":"28","author":"Gray","year":"1995","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.ijid.2019.04.035_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejps.2006.04.004","article-title":"Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese","volume":"29","author":"Guan","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ijid.2019.04.035_bib0050","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1208\/aapsj080112","article-title":"Cytochrome P450s and other enzymes in drug metabolism and toxicity","volume":"8","author":"Guengerich","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.ijid.2019.04.035_bib0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10928-007-9064-2","article-title":"Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria","volume":"34","author":"Hietala","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"10.1016\/j.ijid.2019.04.035_bib0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00228-002-0499-5","article-title":"Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population","volume":"58","author":"Hiratsuka","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ijid.2019.04.035_bib0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2125.2004.02257.x","article-title":"The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria","volume":"59","author":"Hombhanje","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.ijid.2019.04.035_bib0070","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(09)70320-2","article-title":"Pharmacogenetics of antimalarial drugs: effect on metabolism and transport","volume":"9","author":"Kerb","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.04.035_bib0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12936-017-1816-x","article-title":"Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy","volume":"16","author":"Koukouikila-Koussounda","year":"2017","journal-title":"Malar J"},{"issue":"5\u20136","key":"10.1016\/j.ijid.2019.04.035_bib0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-003-0636-9","article-title":"Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data","volume":"59","author":"Li","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ijid.2019.04.035_bib0085","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijid.2019.04.035_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2875-7-106","article-title":"Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children","volume":"7","author":"Maiteki-Sebuguzi","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.ijid.2019.04.035_bib0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/1475-2875-13-420","article-title":"Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations","volume":"13","author":"Marwa","year":"2014","journal-title":"Malar J"},{"issue":"4","key":"10.1016\/j.ijid.2019.04.035_bib0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00228-005-0092-9","article-title":"Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea","volume":"62","author":"Mehlotra","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"year":"2014","series-title":"Politique nationale de lutte contre le paludisme. R\u00e9publique du Congo","author":"MHP","key":"10.1016\/j.ijid.2019.04.035_bib0105"},{"key":"10.1016\/j.ijid.2019.04.035_bib0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.actatropica.2016.01.028","article-title":"Cytochrome P450 2C8*2 allele in Botswana: human genetic diversity and public health implications","volume":"157","author":"Motshoge","year":"2016","journal-title":"Acta Trop"},{"year":"2014","series-title":"Plan strat\u00e9gique national de lutte contre le paludisme 2014\u20132018","author":"NMCP","key":"10.1016\/j.ijid.2019.04.035_bib0115"},{"year":"2016","series-title":"Rapport d\u2019activit\u00e9s du programme national de lutte contre le paludisme, ann\u00e9e 2015","author":"NMCP","key":"10.1016\/j.ijid.2019.04.035_bib0120"},{"issue":"10","key":"10.1016\/j.ijid.2019.04.035_bib0125","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-3156.2005.01490.x","article-title":"Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use","volume":"10","author":"Nsimba","year":"2005","journal-title":"Trop Med Int Health"},{"issue":"11","key":"10.1016\/j.ijid.2019.04.035_bib0130","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/infdis\/jir629","article-title":"Human genetic variation is associated with Plasmodium falciparum drug resistance","volume":"204","author":"Paganotti","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2019.04.035_bib0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2875-11-125","article-title":"Distribution of human CYP2C8*2 allele in three different African populations","volume":"11","author":"Paganotti","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijid.2019.04.035_bib0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.meegid.2014.08.011","article-title":"Absence of the human CYP2C8*3 allele in Ugandan children exposed to Plasmodium falciparum malaria","volume":"27","author":"Paganotti","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijid.2019.04.035_bib0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.clpt.6100122","article-title":"Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa","volume":"82","author":"Parikh","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijid.2019.04.035_bib0150","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","article-title":"Drug-resistant malaria: molecular mechanisms and implications for public health","volume":"585","author":"Petersen","year":"2011","journal-title":"FEBS Lett"},{"issue":"12","key":"10.1016\/j.ijid.2019.04.035_bib0155","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-3156.2005.01525.x","article-title":"Short communication: high prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana","volume":"10","author":"R\u00f6wer","year":"2005","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2019.04.035_bib0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00704-007-0298-0","article-title":"Rainfall and temperature variations over Congo-Brazzaville between 1950 and 1998","volume":"91","author":"Samba","year":"2008","journal-title":"Theor Appl Climatol"},{"key":"10.1016\/j.ijid.2019.04.035_bib0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.arr.2010.06.001","article-title":"Pharmacogenetics of cytochrome P450 (CYP) in the elderly","volume":"9","author":"Seripa","year":"2010","journal-title":"Ageing Res Rev"},{"issue":"5","key":"10.1016\/j.ijid.2019.04.035_bib0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.clpt.2004.12.267","article-title":"Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance","volume":"77","author":"Totah","year":"2005","journal-title":"Clin Pharmacol Ther"},{"year":"2015","series-title":"World malaria report 2015","author":"WHO","key":"10.1016\/j.ijid.2019.04.035_bib0175"},{"year":"2015","series-title":"Guidelines for the treatment of malaria","author":"WHO","key":"10.1016\/j.ijid.2019.04.035_bib0180"},{"year":"2018","series-title":"World malaria report 2018","author":"WHO","key":"10.1016\/j.ijid.2019.04.035_bib0185"},{"year":"2006","series-title":"Profil entomologique du Congo, rapport technique OMS\/Minist\u00e8re de la Sant\u00e9 et de la Population","author":"WHO & MHP","key":"10.1016\/j.ijid.2019.04.035_bib0190"},{"year":"2018","series-title":"Largest ethnic groups in the Republic of the Congo (Brazzaville)","author":"Worldatlas","key":"10.1016\/j.ijid.2019.04.035_bib0195"},{"issue":"2","key":"10.1016\/j.ijid.2019.04.035_bib0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab Rev"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219302061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219302061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:44:46Z","timestamp":1761119086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219302061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"alternative-id":["S1201971219302061"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.04.035","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}